These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15671091)

  • 1. Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid.
    Zatelli MC; Maffei P; Piccin D; Martini C; Rea F; Rubello D; Margutti A; Culler MD; Sicolo N; degli Uberti EC
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2104-9. PubMed ID: 15671091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
    van Hoek M; Hofland LJ; de Rijke YB; van Nederveen FH; de Krijger RR; van Koetsveld PM; Lamberts SW; van der Lely AJ; de Herder WW; Feelders RA
    J Clin Endocrinol Metab; 2009 Feb; 94(2):428-33. PubMed ID: 19017754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
    Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; Vignali C; Margutti A; Bondanelli M; Pansini GC; Pelizzo MR; Culler MD; Degli Uberti EC
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2218-24. PubMed ID: 16569735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro.
    Zatelli MC; Piccin D; Bondanelli M; Tagliati F; De Carlo E; Culler MD; Uberti EC
    Horm Metab Res; 2003 Jun; 35(6):349-54. PubMed ID: 12920656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
    Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
    Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
    Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
    J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
    Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
    Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
    Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly due to GHRH-secreting large bronchial carcinoid. Complete recovery following tumor surgery.
    Bolanowski M; Schopohl J; Marciniak M; Rzeszutko M; Zatonska K; Daroszewski J; Milewicz A; Malczewska J; Badowski R
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):188-92. PubMed ID: 12058343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
    Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella.
    Osella G; Orlandi F; Caraci P; Ventura M; Deandreis D; Papotti M; Bongiovanni M; Angeli A; Terzolo M
    J Endocrinol Invest; 2003 Feb; 26(2):163-9. PubMed ID: 12739745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid.
    Drange MR; Melmed S
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3104-9. PubMed ID: 9745411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
    Zatelli MC; Piccin D; Tagliati F; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Culler MD; degli Uberti EC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
    Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
    J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion.
    Lefebvre S; De Paepe L; Abs R; Rahier J; Selvais P; Maiter D
    Eur J Endocrinol; 1995 Sep; 133(3):320-4. PubMed ID: 7581949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegaly caused by ectopic growth hormone-releasing hormone production from a bronchial carcinoid tumor.
    Gudbjartsson T; Agnarsson BA; Palsson PS; Johannesson A
    Thorac Cardiovasc Surg; 2011 Apr; 59(3):184-5. PubMed ID: 21480145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acromegaly and bronchial carcinoid tumor. Apropos of a case].
    Caron P; Guittard J; Trouillas J; Salvador M; Bayard F
    Ann Endocrinol (Paris); 1992; 53(4):158-61. PubMed ID: 1305802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
    Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
    Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.
    Ezzat S; Asa SL; Stefaneanu L; Whittom R; Smyth HS; Horvath E; Kovacs K; Frohman LA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):555-60. PubMed ID: 8126126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy.
    Butler PW; Cochran CS; Merino MJ; Nguyen DM; Schrump DS; Gorden P
    Pituitary; 2012 Jun; 15(2):260-5. PubMed ID: 20379782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.